CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
+13.96%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$705M
AUM Growth
+$705M
(+6.2%)
Cap. Flow
+$13.9M
Cap. Flow
% of AUM
1.97%
Top 10 Holdings %
Top 10 Hldgs %
40.32%
Holding
99
New
15
Increased
52
Reduced
12
Closed
16
Top Buys
| 1 |
Theravance Biopharma
TBPH
|
$25.4M |
| 2 |
Galapagos
GLPG
|
$18.3M |
| 3 |
Clearside Biomedical
CLSD
|
$13.9M |
| 4 |
Minerva Neurosciences
NERV
|
$10.7M |
| 5 |
RLYP
RELYPSA INC COM
RLYP
|
$8.33M |
Top Sells
| 1 |
Alkermes
ALKS
|
$23.9M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$10.6M |
| 3 |
CELG
Celgene Corp
CELG
|
$10M |
| 4 |
Neurocrine Biosciences
NBIX
|
$9.34M |
| 5 |
Rockwell Medical
RMTI
|
$8.3M |
Sector Composition
| 1 | Healthcare | 87.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MYOK
26
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $9.4M | 1.33% |
758,290
+4,902
| +0.7% | +$60.8K |
|
|
PTLA
27
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $9.35M | 1.33% |
396,000
-304,000
| -43% | -$7.17M |
|
28
Dynavax Technologies
DVAX
$1.19B
| $9.26M | 1.31% |
635,000
-340,000
| -35% | -$4.96M |
|
|
RLYP
29
DELISTED
RELYPSA INC COM
RLYP
| $8.33M | 1.18% |
+450,000
| New | +$8.33M |
|
30
Wave Life Sciences
WVE
$1.27B
| $8.16M | 1.16% |
394,407
+2,328
| +0.6% | +$48.2K |
|
31
Sangamo Therapeutics
SGMO
$161M
| $8.12M | 1.15% |
+1,402,331
| New | +$8.12M |
|
32
DexCom
DXCM
$30.9B
| $7.93M | 1.13% |
100,000
-53,000
| -35% | -$4.2M |
|
|
ACHN
33
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $7.85M | 1.11% |
1,006,128
+506,128
| +101% | +$3.95M |
|
|
SYNH
34
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $7.63M | 1.08% |
+200,000
| New | +$7.63M |
|
35
Seres Therapeutics
MCRB
$162M
| $7.35M | 1.04% |
253,064
+3,064
| +1% | +$88.9K |
|
|
ADXS
36
DELISTED
Advaxis, Inc.
ADXS
| $6.55M | 0.93% |
809,804
+9,804
| +1% | +$79.4K |
|
|
AGEN
37
Agenus
AGEN
$136M
| $6.39M | 0.91% |
1,578,106
+19,106
| +1% | +$77.4K |
|
|
SCTL
38
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $6.19M | 0.88% |
778,288
-1,712
| -0.2% | -$13.6K |
|
|
FWP
39
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $6.16M | 0.87% |
339,175
+4,107
| +1% | +$74.7K |
|
40
Corbus Pharmaceuticals
CRBP
$121M
| $5.98M | 0.85% |
+2,000,000
| New | +$5.98M |
|
41
Ultragenyx Pharmaceutical
RARE
$3.04B
| $5.42M | 0.77% |
110,842
+1,342
| +1% | +$65.6K |
|
42
Collegium Pharmaceutical
COLL
$1.25B
| $5.4M | 0.77% |
455,515
+5,515
| +1% | +$65.4K |
|
|
PFNX
43
DELISTED
Pfenex Inc.
PFNX
| $5.3M | 0.75% |
632,559
+7,659
| +1% | +$64.1K |
|
|
DERM
44
DELISTED
Dermira, Inc.
DERM
| $5.03M | 0.71% |
172,083
+2,083
| +1% | +$60.9K |
|
|
XLRN
45
DELISTED
Acceleron Pharma Inc.
XLRN
| $4.33M | 0.61% |
127,451
-72,549
| -36% | -$2.47M |
|
|
AGRX
46
DELISTED
Agile Therapeutics, Inc
AGRX
| $4.29M | 0.61% |
563,880
+6,827
| +1% | +$45.6K |
|
47
Atara Biotherapeutics
ATRA
$88.7M
| $4.2M | 0.6% |
186,460
+36,460
| +24% | +$820K |
|
48
Iovance Biotherapeutics
IOVA
$800M
| $4.1M | 0.58% |
505,941
+6,126
| +1% | +$49.6K |
|
49
CytomX Therapeutics
CTMX
$350M
| $3.8M | 0.54% |
371,636
+613
| +0.2% | +$6.26K |
|
50
Indaptus Therapeutics
INDP
$5.98M
| $3.72M | 0.53% |
809,804
+9,804
| +1% | +$51.4K |
|